Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Classical hematology 2

Conditions

Venous Thrombosis 3Neoplasms 3Venous Thromboembolism 2Pulmonary Embolism 2Thrombosis 1Prostatic Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Hot Flashes 1Cushing Syndrome 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Advanced Non-small Cell Lung Cancer 1

Interventions

Dalteparin 10apixaban 9Tinzaparin 4Enoxaparin 4Heparin, Low-Molecular-Weight 3edoxaban 2abelacimab 2Rivaroxaban 2MAA868 2Dabigatran 2perflutren 1isoquercitrin 1enoxaparin sodium 1bemiparin 1Warfarin 1Sulfur Hexafluoride 1Rosuvastatin Calcium 1Hospitals 1Fondaparinux 1Fluorodeoxyglucose F18 1Educational Status 1Deoxyribonucleases 1Acetylcysteine 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Pulmonary Embolism × Dabigatran × Clear all
NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

The University of Hong Kong

Phase 3 Unknown
99 enrolled
Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡